{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:52:29Z","timestamp":1791831149755,"version":"4.3.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Key Programs of China","award":["2009ZX09102-045"],"award-info":[{"award-number":["2009ZX09102-045"]}]},{"name":"National Key Programs of China","award":["2009ZX09501-015"],"award-info":[{"award-number":["2009ZX09501-015"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.ejmech.2011.02.033","type":"journal-article","created":{"date-parts":[[2011,2,23]],"date-time":"2011-02-23T09:52:26Z","timestamp":1298454746000},"page":"2003-2010","source":"Crossref","is-referenced-by-count":90,"title":["Synthesis and biological activity of novel barbituric and thiobarbituric acid derivatives against non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"46","author":[{"given":"Liang","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhizhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jincheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangcheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihua","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuquan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2011.02.033_bib1","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Non-alcoholic fatty liver disease","volume":"346","author":"Paul","year":"2002","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2011.02.033_bib2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/pgmj.2005.042200","article-title":"Treatment of non-alcoholic fatty liver disease","volume":"82","author":"Adams","year":"2006","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.ejmech.2011.02.033_bib3","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1046\/j.1440-1746.2003.02989.x","article-title":"Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region?","volume":"18","author":"Farrell","year":"2003","journal-title":"J.\u00a0Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejmech.2011.02.033_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7861\/clinmedicine.6-1-19","article-title":"Non-alcoholic fatty liver disease: current concepts and management strategies","volume":"6","author":"Day","year":"2006","journal-title":"Clin. Med."},{"key":"10.1016\/j.ejmech.2011.02.033_bib5","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Non-alcoholic fatty liver disease: a spectrum of clinical and pathological severity","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejmech.2011.02.033_bib6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/01.mol.0000174153.53683.f2","article-title":"Non-alcoholic fatty liver disease and the metabolic syndrome","volume":"16","author":"Marchesini","year":"2005","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.ejmech.2011.02.033_bib7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1053\/jhep.2002.30692","article-title":"NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome","volume":"35","author":"Chitturi","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2011.02.033_bib8","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","article-title":"Non-alcoholic fatty liver disease: a feature of the metabolic syndrome","volume":"50","author":"Marchesini","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.ejmech.2011.02.033_bib9","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Non-alcoholic fatty liver, steatohepatitis, and the metabolic syndrome","volume":"37","author":"Marchesini","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2011.02.033_bib10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S1043-2760(01)00524-0","article-title":"ACRP30\/adiponectin: an adipokine regulating glucose and lipid metabolism","volume":"13","author":"Berg","year":"2002","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.ejmech.2011.02.033_bib11","doi-asserted-by":"crossref","first-page":"671","DOI":"10.7326\/0003-4819-130-8-199904200-00014","article-title":"The role of leptin in human obesity and disease: a review of current evidence","volume":"130","author":"Mantzoros","year":"1999","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejmech.2011.02.033_bib12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.33549\/physiolres.930600","article-title":"Adiponectin, an adipocyte-derived protein","volume":"54","author":"Nedvidkova","year":"2005","journal-title":"Physiol. Res."},{"key":"10.1016\/j.ejmech.2011.02.033_bib13","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1463-1326.2005.00510.x","article-title":"Adiponectin-a key adipokine in the metabolic syndrome","volume":"8","author":"Whitehead","year":"2006","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.ejmech.2011.02.033_bib14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1172\/JCI200317797","article-title":"The fat-derived hormone adiponectin alleviates alcoholic and non-alcoholic fatty liver diseases in mice","volume":"112","author":"Xu","year":"2003","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ejmech.2011.02.033_bib15","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1161\/01.ATV.20.6.1595","article-title":"Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients","author":"Hotta","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejmech.2011.02.033_bib16","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1530\/eje.1.02288","article-title":"Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease","volume":"155","author":"Valerio","year":"2006","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ejmech.2011.02.033_bib17","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/79697","article-title":"Metformin reverses fatty liver disease in obese, leptin-deficient mice","volume":"6","author":"Lin","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2011.02.033_bib18","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1572-0241.2005.41583.x","article-title":"A\u00a0randomized controlled trial of metformin versus vitamin E or prescriptive diet in non-alcoholic fatty liver disease","volume":"100","author":"Bugianesi","year":"2005","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.ejmech.2011.02.033_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/0003-4819-137-1-200207020-00009","article-title":"Metformin: an update","volume":"137","author":"Kirpichnikov","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejmech.2011.02.033_bib20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/dmrr.249","article-title":"The mode of action of thiazolidinediones","volume":"18","author":"Hans","year":"2002","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.ejmech.2011.02.033_bib21","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nm724","article-title":"Diet-induced insulin resistance in mice lacking adiponectin\/ACRP30","volume":"8","author":"Maeda","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2011.02.033_bib22","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2337\/diacare.25.2.376","article-title":"Synthetic peroxisome proliferator -activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients","volume":"25","author":"Yang","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejmech.2011.02.033_bib23","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1463-1326.2007.00755.x","article-title":"The effect of thiazolidinediones on adiponectin serum level: a meta-analysis","volume":"10","author":"Riera-Guardia","year":"2008","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.ejmech.2011.02.033_bib24","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1053\/j.gastro.2008.03.078","article-title":"Rosiglitazone for non-alcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone therapy (FLIRT) Trial","volume":"135","author":"Ratziu","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejmech.2011.02.033_bib25","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/hep.1840380427","article-title":"Improved non-alcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone","volume":"38","author":"Neuschwander-Tetri","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2011.02.033_bib26","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1016\/j.bmcl.2008.08.028","article-title":"New PPAR \u03b3 ligands based on barbituric acid: virtual screening, synthesis and receptor binding studies","volume":"18","author":"Sandeep","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2011.02.033_bib27","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1021\/jm0601598","article-title":"Furan-2-ylmethylene Thiazolidinediones as novel, potent, and selective inhibitors of phosphoinositide 3-kinase \u03b3","volume":"49","author":"Vincent","year":"2006","journal-title":"J.\u00a0Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523411001449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523411001449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T10:38:27Z","timestamp":1685961507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523411001449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0223523411001449"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2011.02.033","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}